Feature selection and prediction of treatment failure in tuberculosis

PLoS ONE

Volumn 13, Issue 11, 2018, Pages

  Sauer, Christopher Martin ^a,b   Sasson, David ^a   Paik, Kenneth E ^b   McCague, Ned ^b   Celi, Leo Anthony ^b   Fernández, Iván Sánchez ^c   Illigens, Ben M W ^c  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^b Massachusetts Institute of Technology   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMOXICILLIN PLUS CLAVULANIC ACID; BEDAQUILINE; CAPREOMYCIN; CLOFAZIMINE; CLOTIAZEPAM; CYCLOSPORINE; ETHAMBUTOL; TUBERCULOSTATIC AGENT;

ADULT; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ANTIBIOTIC THERAPY; AREA UNDER THE CURVE; ARTICLE; CLINICAL FEATURE; COMPARATIVE STUDY; CONTROLLED STUDY; DEMOGRAPHY; DRUG RESISTANT TUBERCULOSIS; EDUCATIONAL STATUS; EMPLOYMENT STATUS; FEMALE; HUMAN; IMAGING; LUNG CAPACITY; MACHINE LEARNING; MAJOR CLINICAL STUDY; MALE; MICROSCOPY; PREDICTION; PREDICTIVE VALUE; RANDOM FOREST; STAINING; TREATMENT FAILURE; ZIEHL NIELSEN STAIN; EXTENSIVELY DRUG RESISTANT TUBERCULOSIS; FORECASTING; MICROBIOLOGY; MIDDLE AGED; PATHOLOGY; RISK FACTOR; SUPPORT VECTOR MACHINE;

ADULT; ANTITUBERCULAR AGENTS; EXTENSIVELY DRUG-RESISTANT TUBERCULOSIS; FEMALE; FORECASTING; HUMANS; MACHINE LEARNING; MALE; MICROSCOPY; MIDDLE AGED; RISK FACTORS; SUPPORT VECTOR MACHINE; TREATMENT FAILURE;

EID: 85056803154     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0207491     Document Type: Article

References (27)

1. WHO. Global tuberculosis report 2017 2017. Available from: http://apps.who.int/iris/bitstream/10665/259366/1/9789241565516-eng.pdf.
2. CDC. Fact Sheets | Drug-Resistant TB | Extensively Drug-Resistant Tuberculosis (XDR TB) | TB | CDC 2018 [updated 20 Feb 2018]. Available from: https://www.cdc.gov/tb/publications/factsheets/drtb/xdrtb.htm.
3. Sharma A, Hill A, Kurbatova E, van der Walt M, Kvasnovsky C, Tupasi TE, et al. Estimating the future burden of multidrug-resistant and extensively drug-resistant tuberculosis in India, the Philippines, Russia, and South Africa: a mathematical modelling study. Lancet Infect Dis. 2017; 17(7):707–15. Epub 2017/05/14. https://doi.org/10.1016/S1473-3099(17)30247-5 PMID: 28499828; PubMed Central PMCID: PMCPMC5599934.
4. Keane VP, de Klerk N, Krieng T, Hammond G, Musk AW. Risk factors for the development of non-response to first-line treatment for tuberculosis in southern Vietnam. Int J Epidemiol. 1997; 26(5):1115–20. Epub 1997/11/18. PMID: 9363535.
5. Walker TM, Kohl TA, Omar SV, Hedge J, Del Ojo Elias C, Bradley P, et al. Whole-genome sequencing for prediction of Mycobacterium tuberculosis drug susceptibility and resistance: a retrospective cohort study. Lancet Infect Dis. 2015; 15(10):1193–202. Epub 2015/06/28. https://doi.org/10.1016/S1473-3099(15)00062-6 PMID: 26116186; PubMed Central PMCID: PMCPMC4579482.
6. Sielatycki JA, Parker SL, Godil SS, McGirt MJ, Devin CJ. Do Patient Demographics and Patient-Reported Outcomes Predict 12-Month Loss to Follow-Up After Spine Surgery? Spine (Phila Pa 1976). 2015; 40 (24):1934–40. Epub 2015/11/26. https://doi.org/10.1097/brs.0000000000001101 PMID: 26595443.
7. Wilson D, Jin DL, Wen T, Carmichael JD, Cen S, Mack WJ, et al. Demographic factors, outcomes, and patient access to transsphenoidal surgery for Cushing’s disease: analysis of the Nationwide Inpatient Sample from 2002 to 2010. Neurosurg Focus. 2015; 38(2):E2. Epub 2015/02/03. https://doi.org/10.3171/2014.11.FOCUS14694 PMID: 25639320.
8. Rosenthal A, Gabrielian A, Engle E, Hurt DE, Alexandru S, Crudu V, et al. The TB Portals: an Open-Access, Web-Based Platform for Global Drug-Resistant-Tuberculosis Data Sharing and Analysis. J Clin Microbiol. 2017; 55(11):3267–82. Epub 2017/09/15. https://doi.org/10.1128/JCM.01013-17 PMID: 28904183; PubMed Central PMCID: PMCPMC5654911.
9. Beam AL, Kohane IS. Big Data and Machine Learning in Health Care. Jama. 2018; 319(13):1317–8. Epub 2018/03/14. https://doi.org/10.1001/jama.2017.18391 PMID: 29532063.
10. Abu-Mostafa YS M-IM, Lin H-T. Learning from Data: A Short Course2012.
11. James G WD, Hastie T, Tibshirani R. An Introduction to Statistical Learning: with Applications in R: Springer Science & Business Media; 2013.
12. Perkins NJ, Schisterman EF. The inconsistency of "optimal" cutpoints obtained using two criteria based on the receiver operating characteristic curve. Am J Epidemiol. 2006; 163(7):670–5. Epub 2006/01/18. https://doi.org/10.1093/aje/kwj063 PMID: 16410346; PubMed Central PMCID: PMCPMC1444894.
13. Santha T, Garg R, Frieden TR, Chandrasekaran V, Subramani R, Gopi PG, et al. Risk factors associated with default, failure and death among tuberculosis patients treated in a DOTS programme in Tiru-vallur District, South India, 2000. Int J Tuberc Lung Dis. 2002; 6(9):780–8. Epub 2002/09/18. PMID: 12234133.
14. Huang Q, Yin Y, Kuai S, Yan Y, Liu J, Zhang Y, et al. The value of initial cavitation to predict re-treatment with pulmonary tuberculosis. Eur J Med Res. 2016; 21(1):20. Epub 2016/05/08. https://doi.org/10.1186/ s40001-016-0214-0 PMID: 27154410; PubMed Central PMCID: PMCPMC4858857.
15. Mohammadzadeh Kh A, Ghayoomi A, Maghsoudloo D. Evaluation of factors associated with failure of tuberculosis treatment under DOTS in northern Islamic Republic of Iran. East Mediterr Health J. 2016; 22(2):87–94. Epub 2016/05/18. PMID: 27180736.
16. Sharareh R. Niakan Kalhori MN, Zeng Xiao-Jun. A Logistic Regression Model to Predict High Risk Patients to Fail in Tuberculosis Treatment Course Completion. International Journal of Applied Mathematics. 2008.
17. Rodrigo T, Caylà JA, Casals M, García-García JM, Caminero JA, Ruiz-Manzano J, et al. A predictive scoring instrument for tuberculosis lost to follow-up outcome. Respiratory Research. 2012; 13(1):75. https://doi.org/10.1186/1465-9921-13-75 PMID: 22938040
18. Cherkaoui I, Sabouni R, Ghali I, Kizub D, Billioux AC, Bennani K, et al. Treatment Default amongst Patients with Tuberculosis in Urban Morocco: Predicting and Explaining Default and Post-Default Sputum Smear and Drug Susceptibility Results. PLOS ONE. 2014; 9(4):e93574. https://doi.org/10.1371/journal.pone.0093574 PMID: 24699682
19. Kondo N, Sembajwe G, Kawachi I, van Dam RM, Subramanian SV, Yamagata Z. Income inequality, mortality, and self rated health: meta-analysis of multilevel studies. Bmj. 2009; 339:b4471. Epub 2009/ 11/12. https://doi.org/10.1136/bmj.b4471 PMID: 19903981; PubMed Central PMCID: PMCPMC2776131.
20. Subramanian SV, Kawachi I. Income inequality and health: what have we learned so far? Epidemiol Rev. 2004; 26:78–91. Epub 2004/07/06. https://doi.org/10.1093/epirev/mxh003 PMID: 15234949.
21. Lynch J, Smith GD, Harper S, Hillemeier M, Ross N, Kaplan GA, et al. Is income inequality a determinant of population health? Part 1. A systematic review. Milbank Q. 2004; 82(1):5–99. Epub 2004/03/16. https://doi.org/10.1111/j.0887-378X.2004.00302.x PMID: 15016244; PubMed Central PMCID: PMCPMC2690209.
22. Marmot MG, Smith GD, Stansfeld S, Patel C, North F, Head J, et al. Health inequalities among British civil servants: the Whitehall II study. Lancet. 1991; 337(8754):1387–93. Epub 1991/06/08. PMID: 1674771.
23. Khan MS, Hutchison C, Coker RJ. Risk factors that may be driving the emergence of drug resistance in tuberculosis patients treated in Yangon, Myanmar. PLoS ONE. 2017; 12(6):e0177999. https://doi.org/10.1371/journal.pone.0177999 PMC5470668. PMID: 28614357
24. Chen ML, Doddi A, Royer J, Freschi L, Schito M, Ezewudo M, et al. Deep Learning Predicts Tuberculosis Drug Resistance Status from Whole-Genome Sequencing Data. bioRxiv. 2018.
25. Sloan DJ, Mwandumba HC, Garton NJ, Khoo SH, Butterworth AE, Allain TJ, et al. Pharmacodynamic Modeling of Bacillary Elimination Rates and Detection of Bacterial Lipid Bodies in Sputum to Predict and Understand Outcomes in Treatment of Pulmonary Tuberculosis. Clin Infect Dis. 2015; 61(1):1–8. Epub 2015/03/18. https://doi.org/10.1093/cid/civ195 PMID: 25778753; PubMed Central PMCID: PMCPMC4463005.
26. Lopez T, Moreno M, Salvador F, Zacarias A, Carvalho R, Tomas E, et al. Tuberculosis diagnosed in a rural setting in Angola. Accuracy of follow-up sputum smears to predict outcome. Pathog Glob Health. 2013; 107(1):5–10. Epub 2013/02/26. https://doi.org/10.1179/2047773212Y.0000000066 PMID: 23432857; PubMed Central PMCID: PMCPMC4001596.
27. Thompson EG, Du Y, Malherbe ST, Shankar S, Braun J, Valvo J, et al. Host blood RNA signatures predict the outcome of tuberculosis treatment. Tuberculosis (Edinb). 2017; 107:48–58. Epub 2017/10/21. https://doi.org/10.1016/j.tube.2017.08.004 PMID: 29050771; PubMed Central PMCID: PMCPMC5658513.